Delivery Order SPE2DB25D2207-SPE2DB25FQRCM
- Not listed
- The Defense Logistics Agency awarded a $3,176.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Qulipta 30 mg tablets (30-count units) on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-set-aside contract award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $7,481.34 delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count supply) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed price contract represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime...
- The Defense Logistics Agency awarded a $4,047.89 firm fixed price delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Qulipta 60 mg tablets in quantities of 30. This non-competitive delivery order, with a completion date of April 24, 2025, will be fulfilled at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Qulipta 60 mg tablets (30-count packages) under a firm fixed-price contract. The order, valued at $2,400.59, represents a competitive award with no set-aside designation and a completion deadline of July 28, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Qulipta 60 mg, a migraine prevention medication, valued at $1,539.72. This competitively awarded, firm fixed-price delivery order was issued on May 27, 2025, with an ultimate completion date of May 28, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance. The delivery order falls under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,309.58 delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count units) on May 12, 2025, with an ultimate completion date of May 13, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a delivery order valued at $4,755.64 to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets (30-count) on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count packages) under a firm fixed-price contract valued at $1,649.05. The award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive delivery order without set-aside designation. AmerisourceBergen will perform this contract from its corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Qulipta 60 mg tablets (30-count packages) with a contract ceiling value of $5,993.70. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The ultimate completion date is set for July 23, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for Qulipta 60 mg tablets (30-count packaging) on August 19, 2025, with a ceiling value of $3,492.19. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for completion by August 20, 2025, with performance taking place at the contractor's corporate office location in Conshohocken,...
- SPE2DB25D2207Indefinite Delivery Contract
- SPE2DB25D2207-SPE2DB25FQRCMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,471.33 to supply Qulipta 60 mg tablets (30-count packages) for delivery to the company's Conshohocken, Pennsylvania headquarters. This competitively awarded, firm fixed-price contract was executed on June 17, 2025, with an ultimate completion date of June 18, 2025, and carries no set-aside designation. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor for the Defense Logistics Agency and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver a comprehensive range of medications and medical supplies across multiple therapeutic domains, including specialty pharmaceuticals, brand-name and generic drugs, and medical devices. This Qulipta delivery order exemplifies AmerisourceBergen's ongoing role as a primary supplier for military and veteran healthcare systems through competitively awarded contracts that reflect its established competency in meeting federal procurement standards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 6/17/25 |